TEMPO Program for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help men with prostate cancer and their caregivers manage physical and emotional challenges. It tests an online tool called TEMPO, which provides guidance on coping skills and exercise. Participants will either use TEMPO or monitor their anxiety for 12 weeks, with the option to access TEMPO later if needed. This trial suits men diagnosed with prostate cancer who experience moderate anxiety, have a caregiver willing to participate, and have internet access. As an unphased trial, it offers participants the chance to contribute to research that may enhance support tools for managing cancer-related anxiety.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on a web-based program for managing anxiety and physical activity, so it's unlikely that medication changes are required.
What prior data suggests that the TEMPO program is safe for men with prostate cancer and their caregivers?
Research has shown that the TEMPO program helps men with prostate cancer and their caregivers manage physical and emotional challenges. This online program allows patients and caregivers to use it independently. Studies have examined the acceptance and usage of TEMPO.
Specific information about safety risks, such as side effects, is not available. However, as an online program rather than a medication or surgery, it is generally considered low risk. Participants have reported positive outcomes, including better communication and improved coping skills. As a web-based tool, TEMPO is expected to be user-friendly.12345Why are researchers excited about this trial?
Researchers are excited about the TEMPO Program for prostate cancer because it introduces a flexible, stepped care approach that adjusts to each patient's needs. Unlike traditional treatments that might rely solely on medication or surgery, TEMPO offers variations in timing and intensity, allowing for a more personalized experience. The program combines self-directed and guided interventions, empowering patients and caregivers to actively participate in managing their anxiety alongside usual care. This innovative approach aims to enhance patient outcomes by tailoring support to individual circumstances, potentially improving both mental and physical health.
What evidence suggests that the TEMPO program is effective for prostate cancer?
Research has shown that the TEMPO program, which participants in this trial may receive, is designed to help men with prostate cancer and their caregivers manage physical and emotional challenges. Past participants reported improved communication and coping skills, along with increased physical activity. The program is online and interactive, offering support without the need for a healthcare professional. Based on evidence from previous cancer support studies, it aims to reduce anxiety and improve overall health. Users found it practical and helpful, suggesting it effectively meets the needs of those affected by prostate cancer.12467
Who Is on the Research Team?
Sylvie Lambert, PhD
Principal Investigator
McGill University
Are You a Good Fit for This Trial?
This trial is for men with prostate cancer and their caregivers. It's designed to help them manage the emotional and physical challenges of cancer without needing a healthcare professional. Participants will use TEMPO, a web-based program offering coping skills training and exercise routines.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants are randomized to either TEMPO self-directed or active monitoring of anxiety for 12 weeks
Re-randomization and Continued Treatment
Participants needing more support are re-randomized to TEMPO with guidance or continue with TEMPO self-directed; active monitoring group offered TEMPO
Follow-up
Participants are monitored for anxiety and other health outcomes post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- TEMPO
Trial Overview
TEMPO, a self-management program for prostate cancer patients and their caregivers, is being tested against simply monitoring anxiety levels over 12 weeks. The study aims to see if TEMPO improves health outcomes without professional guidance.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Using a stepped care approach, TEMPO will be provided across two intervention stages with variations on timing (initial vs. delayed) and intensity (self-directed vs. guided). All dyads will continue to access usual care (a co-intervention measure is included).
Patients will receive usual care throughout the study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Mary's Research Center, Canada
Lead Sponsor
Université de Montréal
Collaborator
Princess Margaret Hospital, Canada
Collaborator
University of British Columbia
Collaborator
Memorial University of Newfoundland
Collaborator
University of Calgary
Collaborator
Sunnybrook Health Sciences Centre
Collaborator
McGill University
Collaborator
Simon Fraser University
Collaborator
Université de Sherbrooke
Collaborator
Published Research Related to This Trial
Citations
A study protocol for a multicenter randomized pilot trial of a ...
TEMPO is a 10-week, interactive, web-based intervention consisting of five modules designed to help dyads manage their physical and psychosocial needs.
Feasibility, Acceptability, and Clinical Significance of a ...
TEMPO is an evidence-informed program designed for men with prostate cancer and their caregivers (as a dyad) to learn self-management skills based on their ...
Effectiveness of mobile health in symptom management of ...
Studies have shown that the incidence of urinary incontinence among localized prostate cancer was 4%–31%, the incidence of fecal incontinence ...
TEMPO Program for Prostate Cancer
The research highlights that more intensive systemic treatments for metastatic castration-sensitive prostate cancer can improve survival and quality of life, ...
a systematic review and meta-analysis protocol
3 Research has indicated that patients with prostate cancer can achieve positive survival outcomes through surgical interventions, radiation therapy, ...
Effect of Mindfulness for Prostatectomy Outcomes, ...
This clinical trial develops and examines a mindfulness program intended to reduce distress for men with prostate cancer undergoing radical prostatectomy ...
(PDF) Feasibility, Acceptability, and Clinical Significance of ...
The purpose of this study was to pilot TEMPO—the first dyadic, Tailored, wEb-based, psychosocial and physical activity self-Management PrOgram ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.